{"id":"NCT00097448","sponsor":"Massachusetts Eye and Ear Infirmary","briefTitle":"Sudden Deafness Treatment Trial","officialTitle":"Sudden Hearing Loss Multicenter Treatment Trial","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2004-12","primaryCompletion":"2009-10","completion":"2011-03","firstPosted":"2004-11-24","resultsPosted":"2013-04-04","lastUpdate":"2017-04-04"},"enrollment":255,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Sudden Deafness"],"interventions":[{"type":"DRUG","name":"prednisone","otherNames":[]},{"type":"DRUG","name":"methylprednisolone sodium succinate","otherNames":[]}],"arms":[{"label":"1","type":"OTHER"},{"label":"2","type":"EXPERIMENTAL"}],"summary":"This trial aims to compare the efficacy of oral prednisone vs. methylprednisolone injected into the middle ear for the treatment of moderate-to-severe, sudden sensorineural hearing loss (inner ear hearing loss affecting one ear that occurs over less than 72 hours).","primaryOutcome":{"measure":"Hearing Improvement","timeFrame":"2 months","effectByArm":[{"arm":"Oral Steroids","deltaMin":30.7,"sd":21.7},{"arm":"IT Steroids","deltaMin":28.7,"sd":21.5}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":25},"locations":{"siteCount":14,"countries":["United States"]},"refs":{"pmids":["22805100","21610239"],"seeAlso":["http://www.suddendeafness.org"]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":125},"commonTop":["Ear pain","Hyperglycemia","Sleep disturbance","Vertigo","Appetite change"]}}